Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2021 1
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Highly Invasive Fluorescent/Bioluminescent Patient-Derived Orthotopic Model of Glioblastoma in Mice.
Yuzhakova D, Kiseleva E, Shirmanova M, Shcheslavskiy V, Sachkova D, Snopova L, Bederina E, Lukina M, Dudenkova V, Yusubalieva G, Belovezhets T, Matvienko D, Baklaushev V. Yuzhakova D, et al. Among authors: belovezhets t. Front Oncol. 2022 Jul 13;12:897839. doi: 10.3389/fonc.2022.897839. eCollection 2022. Front Oncol. 2022. PMID: 35912166 Free PMC article.
Corrigendum: Highly invasive fluorescent/bioluminescent patient-derived orthotopic model of glioblastoma in mice.
Yuzhakova D, Kiseleva E, Shirmanova M, Shcheslavskiy V, Sachkova D, Snopova L, Bederina E, Lukina M, Dudenkova V, Yusubalieva G, Belovezhets T, Matvienko D, Baklaushev V. Yuzhakova D, et al. Among authors: belovezhets t. Front Oncol. 2022 Sep 29;12:1040637. doi: 10.3389/fonc.2022.1040637. eCollection 2022. Front Oncol. 2022. PMID: 36248972 Free PMC article.
Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern.
Gorchakov AA, Kulemzin SV, Guselnikov SV, Baranov KO, Belovezhets TN, Mechetina LV, Volkova OY, Najakshin AM, Chikaev NA, Chikaev AN, Solodkov PP, Larichev VF, Gulyaeva MA, Markhaev AG, Kononova YV, Alekseyev AY, Shestopalov AM, Yusubalieva GM, Klypa TV, Ivanov AV, Valuev-Elliston VT, Baklaushev VP, Taranin AV. Gorchakov AA, et al. Among authors: belovezhets tn. Cell Discov. 2021 Oct 19;7(1):96. doi: 10.1038/s41421-021-00340-8. Cell Discov. 2021. PMID: 34667147 Free PMC article.
Humoral Immune Responses in Patients with Severe COVID-19: A Comparative Pilot Study between Individuals Infected by SARS-CoV-2 during the Wild-Type and the Delta Periods.
Sukhova M, Byazrova M, Mikhailov A, Yusubalieva G, Maslova I, Belovezhets T, Chikaev N, Vorobiev I, Baklaushev V, Filatov A. Sukhova M, et al. Among authors: belovezhets t. Microorganisms. 2023 Sep 20;11(9):2347. doi: 10.3390/microorganisms11092347. Microorganisms. 2023. PMID: 37764191 Free PMC article.
Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies.
Solodkov PP, Najakshin AM, Chikaev NA, Kulemzin SV, Mechetina LV, Baranov KO, Guselnikov SV, Gorchakov AA, Belovezhets TN, Chikaev AN, Volkova OY, Markhaev AG, Kononova YV, Alekseev AY, Gulyaeva MA, Shestopalov AM, Taranin AV. Solodkov PP, et al. Among authors: belovezhets tn. Vaccines (Basel). 2024 Jan 26;12(2):129. doi: 10.3390/vaccines12020129. Vaccines (Basel). 2024. PMID: 38400113 Free PMC article.
12 results